Lucid Diagnostics Inc. (LUCD) Return on equity 2021–2025
Lucid Diagnostics Inc. (LUCD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-530.4%FY2025 · since FY2021: -51.3% → -530.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -530.4% | +314.1 pp |
| FY2024 | -844.5% | — |
| FY2022 | -243.7% | -192.4 pp |
| FY2021 | -51.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LUCD financial trends
LUCD RevenueLUCD Net incomeLUCD Net marginLUCD Gross profitLUCD Gross marginLUCD Operating incomeLUCD Operating marginLUCD Operating cash flowLUCD Free cash flowLUCD Capital expendituresLUCD Stock buybacksLUCD Dividends paidLUCD Total assetsLUCD Total liabilitiesLUCD Shareholders’ equityLUCD overview →